Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-1|1|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-2|1|330|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-3|1|391|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-4|1|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-5|1|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-6|1|471|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-7|1|472|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-8|1|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-9|1|526|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-10|1|534|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-11|1|535|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-12|1|545|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-13|1|552|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-14|1|556|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-15|1|562|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-16|1|563|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-17|1|569|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-18|1|587|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-19|1|605|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-20|1|605|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-21|1|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-22|1|631|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-23|1|642|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-24|1|645|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-25|1|646|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-26|1|647|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-27|1|654|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-28|1|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-29|1|661|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-30|1|661|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-31|1|672|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-32|1|675|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-33|1|675|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-34|1|686|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-35|1|687|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-36|1|692|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-37|1|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-38|1|699|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-39|1|714|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-40|1|721|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-41|1|723|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-42|1|737|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-43|1|762|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-44|1|771|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-45|1|779|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-46|1|791|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-47|1|793|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-48|1|808|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-49|1|875|n/a|n/a|n/a|
5-4-1|n/a,FK KO 7/82|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-1-50|1|958|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-1|2|13|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-2|2|13|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-3|2|57|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-4|2|58|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-5|2|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-6|2|267|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-7|2|272|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-8|2|282|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-9|2|282|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-10|2|286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-11|2|297|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-12|2|332|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-13|2|345|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-14|2|346|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-15|2|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-16|2|377|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-17|2|385|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-18|2|399|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-19|2|399|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-20|2|400|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-21|2|402|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-22|2|402|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-23|2|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-24|2|406|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-25|2|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-26|2|426|Neoplasia systemic|Haematolymphatic system|L|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-27|2|436|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-28|2|454|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-29|2|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-30|2|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-31|2|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-32|2|482|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-33|2|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-34|2|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-35|2|493|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-36|2|500|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-37|2|506|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-38|2|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-39|2|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-40|2|520|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-41|2|521|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-42|2|524|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-43|2|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-44|2|538|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-45|2|539|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-46|2|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.-lymphatic leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-47|2|549|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-48|2|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-49|2|574|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-50|2|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-51|2|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-52|2|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-53|2|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-54|2|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-55|2|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-56|2|672|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-57|2|673|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|1|30|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-58|2|703|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-1|2|13|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-2|2|13|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-3|2|57|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-4|2|58|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-5|2|188|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-6|2|267|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-7|2|272|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-8|2|282|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-9|2|282|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-10|2|286|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-11|2|297|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-12|2|332|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-13|2|345|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-14|2|346|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-15|2|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-16|2|377|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-17|2|385|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-18|2|399|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-19|2|399|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-20|2|400|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-21|2|402|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-22|2|402|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-23|2|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-24|2|406|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-25|2|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-26|2|426|Neoplasia systemic|Haematolymphatic system|L|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-27|2|436|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-28|2|454|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-29|2|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-30|2|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-31|2|469|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-32|2|482|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-33|2|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-34|2|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-35|2|493|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-36|2|500|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-37|2|506|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-38|2|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-39|2|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-40|2|520|n/a|n/a|n/a|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-41|2|521|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-42|2|524|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-43|2|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-44|2|538|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-45|2|539|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-46|2|541|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.-lymphatic leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-47|2|549|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-48|2|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-49|2|574|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-50|2|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-51|2|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-52|2|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-53|2|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-54|2|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-55|2|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-56|2|672|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-57|2|673|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-2|n/a,FK J 7/82|2|150|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|n/a|58 (58 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-2-58|2|703|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-1|3|164|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-2|3|331|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-3|3|370|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-4|3|402|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-5|3|407|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-6|3|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-7|3|425|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-8|3|450|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-9|3|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-10|3|456|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-11|3|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-12|3|468|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-13|3|472|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-14|3|472|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-15|3|478|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-16|3|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-17|3|492|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-18|3|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-19|3|503|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-20|3|513|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-21|3|520|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-22|3|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-23|3|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-24|3|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-25|3|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-26|3|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-27|3|535|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-28|3|542|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-29|3|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-30|3|570|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-31|3|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-32|3|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-33|3|584|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-34|3|587|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-35|3|593|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-36|3|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-37|3|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-38|3|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-39|3|603|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-40|3|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-41|3|611|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-42|3|625|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-43|3|631|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-44|3|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-45|3|650|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-46|3|652|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-47|3|671|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-48|3|682|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-49|3|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-50|3|710|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-51|3|715|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-52|3|731|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-53|3|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|1|91|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-54|3|745|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-1|3|164|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-2|3|331|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-3|3|370|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-4|3|402|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-5|3|407|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-6|3|415|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-7|3|425|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-8|3|450|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-9|3|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-10|3|456|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-11|3|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-12|3|468|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-13|3|472|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-14|3|472|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-15|3|478|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-16|3|486|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-17|3|492|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-18|3|499|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-19|3|503|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-20|3|513|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-21|3|520|n/a|n/a|n/a|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-22|3|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-23|3|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-24|3|533|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-25|3|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-26|3|535|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-27|3|535|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-28|3|542|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-29|3|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-30|3|570|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-31|3|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-32|3|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-33|3|584|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-34|3|587|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-35|3|593|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-36|3|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-37|3|594|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-38|3|596|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-39|3|603|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-40|3|605|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-41|3|611|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-42|3|625|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-43|3|631|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-44|3|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-45|3|650|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-46|3|652|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-47|3|671|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-48|3|682|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-49|3|696|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-50|3|710|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-51|3|715|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-52|3|731|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-53|3|737|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-3|n/a,FK F 7/82|2|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|54 (54 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-3-54|3|745|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-1|4|280|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-2|4|283|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-3|4|331|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-4|4|399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-5|4|437|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-6|4|437|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-7|4|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-8|4|461|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-9|4|476|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-10|4|496|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-11|4|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-12|4|498|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-13|4|503|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-14|4|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-15|4|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-16|4|526|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-17|4|526|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-18|4|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-19|4|527|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-20|4|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-21|4|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-22|4|535|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-23|4|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-24|4|539|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-25|4|546|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-26|4|551|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-27|4|552|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-28|4|561|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-29|4|562|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-30|4|566|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-31|4|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-32|4|570|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-33|4|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-34|4|575|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-35|4|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-36|4|581|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-37|4|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-38|4|589|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-39|4|590|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-40|4|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-41|4|591|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-42|4|596|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-43|4|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-44|4|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-45|4|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-46|4|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-47|4|611|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-48|4|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-49|4|617|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-50|4|624|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-51|4|626|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-52|4|629|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-53|4|630|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-54|4|632|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-55|4|632|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-56|4|632|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-57|4|637|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-58|4|639|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-59|4|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-60|4|650|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-61|4|653|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-62|4|657|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-63|4|670|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-64|4|679|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-65|4|689|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-66|4|693|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-67|4|706|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-68|4|707|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-69|4|709|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-70|4|731|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-71|4|738|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-72|4|741|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-73|4|744|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-74|4|745|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-75|4|751|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-76|4|751|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-77|4|785|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-78|4|877|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|1|365|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-79|4|945|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-1|4|280|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-2|4|283|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-3|4|331|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-4|4|399|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-5|4|437|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-6|4|437|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-7|4|461|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-8|4|461|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-9|4|476|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-10|4|496|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-11|4|497|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-12|4|498|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-13|4|503|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-14|4|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-15|4|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-16|4|526|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-17|4|526|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-18|4|526|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-19|4|527|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-20|4|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-21|4|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-22|4|535|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-23|4|535|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-24|4|539|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-25|4|546|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-26|4|551|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-27|4|552|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-28|4|561|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-29|4|562|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-30|4|566|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-31|4|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-32|4|570|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-33|4|574|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-34|4|575|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-35|4|580|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-36|4|581|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-37|4|584|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-38|4|589|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-39|4|590|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-40|4|591|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-41|4|591|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-42|4|596|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-43|4|597|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-44|4|597|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-45|4|604|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-46|4|609|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-47|4|611|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-48|4|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-49|4|617|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-50|4|624|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-51|4|626|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-52|4|629|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-53|4|630|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-54|4|632|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-55|4|632|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-56|4|632|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-57|4|637|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-58|4|639|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-59|4|647|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-60|4|650|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-61|4|653|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-62|4|657|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-63|4|670|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-64|4|679|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-65|4|689|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-66|4|693|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-67|4|706|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-68|4|707|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-69|4|709|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-70|4|731|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-71|4|738|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-72|4|741|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-73|4|744|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-74|4|745|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-75|4|751|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-76|4|751|n/a|n/a|n/a|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-77|4|785|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-78|4|877|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-4|n/a,FK A 7/82|2|426|Th-227 citrate|74|becquerels per g animal|Injection, intraperitoneal|as 2 inject. over 2 w|79 (79 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-4-79|4|945|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-1|5|291|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 335 - hematopoietic/lymphoid malignancies/disorder|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-2|5|344|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-3|5|392|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-4|5|400|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-5|5|411|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-6|5|417|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-7|5|468|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-8|5|483|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-9|5|547|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-10|5|551|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-11|5|556|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-12|5|556|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-13|5|564|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-14|5|565|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-15|5|566|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-16|5|571|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-17|5|594|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-18|5|599|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-19|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-20|5|607|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-21|5|613|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-22|5|614|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-23|5|615|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-24|5|617|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-25|5|622|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-26|5|635|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-27|5|636|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-28|5|672|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-29|5|680|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-30|5|687|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-31|5|694|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-32|5|697|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-33|5|708|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-34|5|712|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-35|5|721|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-36|5|735|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-37|5|747|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-38|5|754|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-39|5|754|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-40|5|777|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-41|5|784|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-42|5|795|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-43|5|811|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-44|5|816|n/a|n/a|n/a|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-45|5|816|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-46|5|820|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-47|5|827|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-48|5|845|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-49|5|922|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-5|n/a,FKL KO 9/83|1|n/a|none (controls)||unit code not relevant|not applicable or not supplied|n/a|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Unknown|full pathology|5-4-5-50|5|1002|n/a|n/a|n/a|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-1|6|21|n/a|n/a|n/a|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-2|6|106|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-3|6|146|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-4|6|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-5|6|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-6|6|150|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-7|6|154|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-8|6|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-9|6|155|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-10|6|161|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-11|6|164|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-12|6|175|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-13|6|180|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-14|6|181|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-15|6|217|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-16|6|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-17|6|221|Neoplasia unclassified|Pituitary gland and epiphysis among endocrine systems,MA: 0000176 - pituitary gland|a  ,MPATH: 218 - neoplasm|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-18|6|229|n/a|n/a|n/a|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-19|6|249|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-20|6|258|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-21|6|264|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-22|6|270|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-23|6|279|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-24|6|295|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-25|6|314|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-26|6|316|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-27|6|322|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-28|6|336|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-29|6|340|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-30|6|344|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-31|6|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-32|6|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-33|6|386|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-34|6|400|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-35|6|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-36|6|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-37|6|424|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-38|6|431|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-39|6|433|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-40|6|435|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-41|6|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-42|6|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-43|6|462|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-44|6|487|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-45|6|495|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-46|6|504|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-47|6|551|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone|b  ,MPATH: 218 - neoplasm|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-48|6|553|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-49|6|601|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-6|n/a,FKL J 9/83|1|91|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|50 (50 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-6-50|6|648|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-1|7|138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-2|7|144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-3|7|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-4|7|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-5|7|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-6|7|225|n/a|n/a|n/a|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-7|7|287|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-8|7|294|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-9|7|336|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-10|7|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-11|7|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-12|7|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-13|7|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-14|7|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-15|7|390|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-16|7|398|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-17|7|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-18|7|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-19|7|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-20|7|413|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-21|7|418|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-22|7|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-23|7|424|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-24|7|433|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-25|7|445|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-26|7|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-27|7|449|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-28|7|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-29|7|452|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-30|7|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-31|7|459|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-32|7|462|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-33|7|470|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-34|7|473|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-35|7|475|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-36|7|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-37|7|477|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-38|7|480|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-39|7|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-40|7|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-41|7|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-42|7|487|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-43|7|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-44|7|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-45|7|497|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-46|7|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-47|7|515|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-48|7|516|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-49|7|522|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-50|7|523|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-51|7|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-52|7|529|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-53|7|531|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-54|7|537|n/a|n/a|n/a|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-55|7|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-56|7|546|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-57|7|550|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-58|7|553|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-59|7|558|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-60|7|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-61|7|572|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-62|7|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-63|7|581|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-64|7|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-65|7|586|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-66|7|587|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-67|7|599|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-68|7|600|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-69|7|601|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone,MA: 0001459 - bone|b  ,MPATH: 393 - osteoblastoma,MPATH: 395 - osteofibroma|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-70|7|602|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-71|7|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-72|7|610|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-73|7|620|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-74|7|630|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-75|7|631|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-76|7|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-77|7|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-78|7|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-79|7|692|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|1|91|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-80|7|700|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-1|7|138|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-2|7|144|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-3|7|157|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-4|7|203|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-5|7|218|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-6|7|225|n/a|n/a|n/a|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-7|7|287|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-8|7|294|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-9|7|336|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-10|7|357|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-11|7|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-12|7|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-13|7|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-14|7|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-15|7|390|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-16|7|398|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-17|7|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-18|7|406|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-19|7|411|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-20|7|413|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-21|7|418|Neoplasia malignant|Bone among musculo-skeletal system diseases,MA: 0000018 - skeletal system|M  ,MPATH: 551 - sarcoma|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-22|7|420|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-23|7|424|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-24|7|433|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-25|7|445|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-26|7|446|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-27|7|449|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-28|7|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-29|7|452|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-30|7|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-31|7|459|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-32|7|462|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-33|7|470|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-34|7|473|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-35|7|475|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-36|7|475|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-37|7|477|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-38|7|480|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-39|7|482|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-40|7|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-41|7|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-42|7|487|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-43|7|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-44|7|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-45|7|497|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-46|7|510|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-47|7|515|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-48|7|516|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-49|7|522|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-50|7|523|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-51|7|525|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-52|7|529|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-53|7|531|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-54|7|537|n/a|n/a|n/a|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-55|7|537|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-56|7|546|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-57|7|550|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-58|7|553|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-59|7|558|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-60|7|566|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-61|7|572|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-62|7|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-63|7|581|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-64|7|585|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-65|7|586|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-66|7|587|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-67|7|599|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-68|7|600|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-69|7|601|Neoplasia benign|Bone among musculo-skeletal system diseases,MA: 0001459 - bone,MA: 0001459 - bone|b  ,MPATH: 393 - osteoblastoma,MPATH: 395 - osteofibroma|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-70|7|602|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-71|7|603|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-72|7|610|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-73|7|620|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-74|7|630|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-75|7|631|Neoplasia unclassified|Lower respiratory system,MA: 0000415 - lung|M  ,MPATH: 218 - neoplasm|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-76|7|637|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-77|7|658|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-78|7|673|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-79|7|692|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-7|n/a,FKL F 9/83|2|304|Lu-177 citrate|186|becquerels per g animal|Injection, intraperitoneal|as 6 inject. over 6 m|80 (80 in ERA)|Mouse|Mouse, NMRI|Female|Young Adult|full pathology|5-4-7-80|7|700|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-1|8|123|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-2|8|176|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-3|8|228|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-4|8|259|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-5|8|262|n/a|n/a|n/a|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-6|8|285|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-7|8|306|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-8|8|312|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-9|8|312|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-10|8|312|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-11|8|316|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-12|8|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-13|8|320|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-14|8|323|n/a|n/a|n/a|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-15|8|327|n/a|n/a|n/a|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-16|8|329|n/a|n/a|n/a|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-17|8|341|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-18|8|341|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-19|8|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-20|8|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-21|8|365|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-22|8|371|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-23|8|378|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-24|8|385|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-25|8|392|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-26|8|396|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-27|8|403|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-28|8|405|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-29|8|417|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-30|8|418|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-31|8|418|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-32|8|418|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-33|8|426|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-Ret.A,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-34|8|432|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-35|8|433|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-36|8|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-37|8|438|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-38|8|441|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-39|8|452|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-40|8|452|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-41|8|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-42|8|455|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-43|8|458|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-44|8|466|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-45|8|468|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-46|8|473|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-47|8|473|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-48|8|477|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-49|8|480|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-50|8|481|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-51|8|482|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-52|8|483|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-53|8|483|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-54|8|484|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-55|8|487|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-56|8|490|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-57|8|491|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-58|8|491|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-59|8|494|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-60|8|494|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-61|8|494|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-62|8|494|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-63|8|496|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-64|8|497|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-65|8|501|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L   Ret.B-lymphatic Leukemia,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-66|8|511|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-67|8|511|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-68|8|511|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-69|8|512|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-70|8|515|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-71|8|516|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-72|8|529|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-73|8|531|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-74|8|531|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-75|8|532|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-76|8|544|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-77|8|547|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-78|8|550|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-79|8|552|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-80|8|552|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-81|8|553|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-82|8|565|Neoplasia unclassified|Other local manifestations and miscellaneus,MA: 0000003 - organ system|a  ,MPATH: 218 - neoplasm|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-83|8|568|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-84|8|572|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-85|8|573|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-86|8|573|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-87|8|575|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-88|8|579|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-89|8|585|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-90|8|586|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-91|8|588|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-92|8|593|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-93|8|607|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-94|8|608|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-95|8|636|n/a|n/a|n/a|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-96|8|666|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-97|8|669|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-98|8|672|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-99|8|677|Neoplasia malignant|Bone among musculo-skeletal system diseases|M|
5-4-8|n/a,FKL A 9/83|1|304|Lu-177 citrate|372|becquerels per g animal|Injection, intraperitoneal|as 12 inject. over 12 m|100 (100 in ERA)|Mouse|Mouse, NMRI|Female|Adult|full pathology|5-4-8-100|8|743|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|L  ,MPATH: 513 - Lymphoid neoplasms|
